Evidence map›Paper›PMID 29704433›Full record

ArticleBiotechnology and bioengineering2018

Retrievable hydrogels for ovarian follicle transplantation and oocyte collection.

Peter D Rios, Ekaterina Kniazeva, Hoi Chang Lee, Shuo Xiao, Robert S Oakes, Eiji Saito, Jacqueline S Jeruss, Ariella Shikanov, Teresa K Woodruff, Lonnie D Shea

Open access · greenAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Peter D RiosDepartment of Biomedical Engineering, Northwestern University, Evanston, Illinois.
Ekaterina KniazevaDepartment of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois.
Hoi Chang LeeDepartment of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois.
Shuo XiaoDepartment of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois.
Robert S OakesDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.
Eiji SaitoDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.
Jacqueline S JerussDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.
Ariella ShikanovDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.
Teresa K WoodruffRobert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.
Lonnie D SheaDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9296-9673
Northwestern University · USUniversity of Michigan · US

Funding

Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-CancerP50HD076188 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2014 to 2017
$6.2M
An in vivo metastasis sensorR01CA173745 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BACKMAN, VADIM, SHEA, LONNIE D · 2012 to 2016
$4.2M
P30A: Biomaterials Core (6 of 10)PL1EB008542 · NIBIB · NORTHWESTERN UNIVERSITY · PI SHEA, LONNIE D · 2007 to 2011
$2.3M
NCI NIH HHS R01 CA173745NIBIB NIH HHS PL1 EB008542NICHD NIH HHS P50 HD076188
6 · The paper itself

Abstract

Cancer survivorship rates have drastically increased due to improved efficacy of oncologic treatments. Consequently, clinical concerns have shifted from solely focusing on survival to quality of life, with fertility preservation as an important consideration. Among fertility preservation strategies for female patients, ovarian tissue cryopreservation and subsequent reimplantation has been the only clinical option available to cancer survivors with cryopreserved tissue. However, follicle atresia after transplantation and risk of reintroducing malignant cells have prevented this procedure from becoming widely adopted in clinics. Herein, we investigated the encapsulation of ovarian follicles in alginate hydrogels that isolate the graft from the host, yet allows for maturation after transplantation at a heterotopic (i.e., subcutaneous) site, a process we termed in vivo follicle maturation. Survival of multiple follicle populations was confirmed via histology, with the notable development of the antral follicles. Collected oocytes (63%) exhibited polar body extrusion and were fertilized by intracytoplasmic sperm injection and standard in vitro fertilization procedures. Successfully fertilized oocytes developed to the pronucleus (14%), two-cell (36%), and four-cell (7%) stages. Furthermore, ovarian follicles cotransplanted with metastatic breast cancer cells within the hydrogels allowed for retrieval of the follicles, and no mice developed tumors after removal of the implant, confirming that the hydrogel prevented seeding of disease within the host. Collectively, these findings demonstrate a viable option for safe use of potentially cancer-laden ovarian donor tissue for in vivo follicle maturation within a retrievable hydrogel and subsequent oocyte collection. Ultimately, this technology may provide novel options to preserve fertility for young female patients with cancer.

Indexed as

Hydrogel, Polyethylene Glycol DimethacrylateOocyte RetrievalAnimalsFemaleFertilization in VitroMiceModels, AnimalNeoplasm TransplantationOrgan TransplantationOvarian FollicleHydrogel, Polyethylene Glycol Dimethacrylatealginatebiomaterialfolliclehydrogeloocyte

Identifiers

PMID29704433
PMCPMC6045426
OpenAlexW2800998848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.